Literature DB >> 16979510

Methamphetamine use and HIV symptom self-management.

Linda Robinson1, Harvey Rempel.   

Abstract

This study describes HIV-related symptoms in a methamphetamine-using sample of 20 men living in southern California. Data were obtained in 2004 and 2005 using a cross-sectional design. Participants were administered the Revised Sign and Symptom Check-List for Persons With HIV Disease and the Addiction Severity Index and were engaged in a semistructured interview. Participants reported using methamphetamine to treat HIV-related depression, fatigue, and neuropathic pain. HIV-related diarrhea seemed to diminish with methamphetamine use, although this was not a motivation for use. These results, although preliminary, suggest that further study of the interplay between methamphetamine use and HIV symptom management is warranted.

Entities:  

Mesh:

Year:  2006        PMID: 16979510     DOI: 10.1016/j.jana.2006.07.003

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  8 in total

1.  Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions.

Authors:  Giordano de Guglielmo; Yu Fu; Jihuan Chen; Estefania Larrosa; Ivy Hoang; Tomoya Kawamura; Irene Lorrai; Barry Zorman; Joseph Bryant; Olivier George; Pavel Sumazin; Celine Lefebvre; Vez Repunte-Canonigo; Pietro Paolo Sanna
Journal:  Brain Res       Date:  2019-10-09       Impact factor: 3.252

2.  Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results.

Authors:  Sheldon R Morris; Susan J Little; Terry Cunningham; Richard S Garfein; Douglas D Richman; Davey M Smith
Journal:  Ann Intern Med       Date:  2010-06-15       Impact factor: 25.391

3.  Relationships over time between mental health symptoms and transmission risk among persons living with HIV.

Authors:  W Scott Comulada; Mary Jane Rotheram-Borus; Willo Pequegnat; Robert E Weiss; Katherine A Desmond; Elizabeth Mayfield Arnold; Robert H Remien; Stephen F Morin; Lance S Weinhardt; Mallory O Johnson; Margaret A Chesney
Journal:  Psychol Addict Behav       Date:  2010-03

4.  Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.

Authors:  James P Kesby; David T Hubbard; Athina Markou; Svetlana Semenova
Journal:  Addict Biol       Date:  2012-12-18       Impact factor: 4.280

5.  Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat.

Authors:  Xiangqian Liu; Linda Chang; Michael Vigorito; Marley Kass; He Li; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2009-05-15       Impact factor: 4.147

6.  HIV-related symptoms and patient clusters among Chileans living with HIV.

Authors:  A X Araya; K F Norr; C M Pérez; J A Levy; C G Park; M J Kim
Journal:  AIDS Care       Date:  2012-08-22

7.  Illicit drug use and HIV treatment outcomes in a US cohort.

Authors:  Joseph Cofrancesco; Rebecca Scherzer; Phyllis C Tien; Cynthia L Gibert; Heather Southwell; Stephen Sidney; Adrian Dobs; Carl Grunfeld
Journal:  AIDS       Date:  2008-01-30       Impact factor: 4.177

8.  Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain.

Authors:  Cathleen M Beliveau; Vanessa M McMahan; Justine Arenander; Martin S Angst; Margot Kushel; Andrea Torres; Glenn-Milo Santos; Phillip O Coffin
Journal:  Subst Abus       Date:  2021-04-02       Impact factor: 3.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.